2018
DOI: 10.1126/science.aas9129
|View full text |Cite
|
Sign up to set email alerts
|

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Abstract: The RNA-guided endonuclease Cas9 cleaves its target DNA and is a powerful genome-editing tool. However, the widely used Cas9 enzyme (SpCas9) requires an NGG protospacer adjacent motif (PAM) for target recognition, thereby restricting the targetable genomic loci. Here, we report a rationally engineered SpCas9 variant (SpCas9-NG) that can recognize relaxed NG PAMs. The crystal structure revealed that the loss of the base-specific interaction with the third nucleobase is compensated by newly introduced non-base-s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

33
714
1
7

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 842 publications
(759 citation statements)
references
References 25 publications
33
714
1
7
Order By: Relevance
“…nCas9(D10A)‐AID showed the highest editing frequency over 95% for targets with the canonical NGG PAM (Figure b and Table S6). Weak NAG PAM and non‐canonical NGA PAMs were also captured by nCas9(D10A)‐AID for base editing, which was consistent with previous reports (Hu et al, ; Nishimasu et al, ). The editing frequencies for targets with NAG or NGA PAMs suggest bias against a C in the +1 position of PAM sequence as previously suggested (Leenay et al, ).…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…nCas9(D10A)‐AID showed the highest editing frequency over 95% for targets with the canonical NGG PAM (Figure b and Table S6). Weak NAG PAM and non‐canonical NGA PAMs were also captured by nCas9(D10A)‐AID for base editing, which was consistent with previous reports (Hu et al, ; Nishimasu et al, ). The editing frequencies for targets with NAG or NGA PAMs suggest bias against a C in the +1 position of PAM sequence as previously suggested (Leenay et al, ).…”
Section: Resultssupporting
confidence: 91%
“…The editing efficiencies of nCas9‐NG(D10A)‐AID with NG PAMs were 3‐ to 28‐fold higher than nCas9(D10A)‐AID and 1.5‐ to 4.2‐ fold higher than nxCas9 3.7(D10A)‐AID (Figure ). Editing events at targets with several NA PAMs were also observed, such as GAT, AAT, GAA, and CAT (Figure b and Table S6), which were consistent with the slight recognition of NA PAMs reported by its inventors (Nishimasu et al, ). Although application of xCas9 3.7 and Cas9‐NG expanded the targeting scope for base editing, the editing window and product purity were generally not changed (Figures S4‐S7 and Table S6).…”
Section: Resultssupporting
confidence: 86%
“…The engineered variant Cas9‐NG was reported to have higher editing efficiency than xCas9 at NG sites in human cells (Nishimasu et al ). We introduced the reported point mutations R1335V/L1111R/D1135V/G1218R/E1219F/A1322R/T1337R (Nishimasu et al ) in plant codon‐optimized SpCas9 to generate Cas9‐NG using overlap PCR (Figure A, Table S1). In addition, we combined the xCas9 mutations with Cas9‐NG mutations (A262T/R324L/S409I/E408K/E543D/M694I/R1335V/L1111R/D1135V/G1218R/E1219F/A1322R/T1337R) to generate the XNG‐Cas9 using overlap PCR (Figure A).…”
Section: Resultsmentioning
confidence: 99%
“…The target sequences of the most widely used Cas, SpCas9, are restricted to genomic sites containing an NGG protospacer adjacent motif (PAM), thus limiting the availability of suitable target sites and reducing the utility of SpCas9. Recently, the SpCas9 variants xCas9 and Cas9‐NG have been developed to recognize not only the canonical NGG PAM but also NG, GAA and GAT PAMs in human cells (Hu et al ; Nishimasu et al ). These variants have also been adapted to expand the scope of CRISPR/Cas9 genome editing in Arabidopsis and rice (Kang et al ; Wang et al ; Ge et al ; Hua et al , ; Wang et al ).…”
Section: Introductionmentioning
confidence: 99%
“…The requirement of a PAM sequence (e.g., NGG for SpdCas9) inherently limits the number of potential target sequences [157,158]. This may be overcome either by dCas9 enzyme engineered to recognize more PAM sequences [51,159] or by using other CRISPRi systems such as that based on ddCas12a [160,161].…”
Section: Limitations Of Crispri and Future Directionsmentioning
confidence: 99%